Plus, news about AbbVie, MindMed, Oculis, Veru, Sensei Biotherapeutics and Eagle Pharmaceuticals:
🤝 Boehringer Ingelheim to pay up to €640M to license Kyowa Kirin program: The German drugmaker now has the ...
↧